Progyny, Inc. (NASDAQ:PGNY) Receives $24.82 Consensus Target Price from Brokerages

Shares of Progyny, Inc. (NASDAQ:PGNY) have been given an average rating of “Hold” by the thirteen analysts that are presently covering the stock, MarketBeat Ratings reports. Nine research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $24.82.

Several equities analysts have commented on PGNY shares. Bank of America lifted their target price on shares of Progyny from $21.00 to $25.00 and gave the stock a “buy” rating in a research report on Tuesday, February 11th. JPMorgan Chase & Co. lifted their price target on Progyny from $17.00 to $23.00 and gave the stock a “neutral” rating in a report on Tuesday, January 28th. Finally, Canaccord Genuity Group upped their price objective on Progyny from $17.00 to $23.00 and gave the company a “hold” rating in a research note on Friday, February 28th.

Progyny Price Performance

PGNY opened at $21.84 on Thursday. Progyny has a fifty-two week low of $13.39 and a fifty-two week high of $38.98. The firm has a market capitalization of $1.87 billion, a P/E ratio of 37.66, a PEG ratio of 2.39 and a beta of 1.41. The company’s 50-day moving average is $22.01 and its 200 day moving average is $18.55.

Institutional Investors Weigh In On Progyny

Several institutional investors have recently added to or reduced their stakes in PGNY. Signaturefd LLC lifted its stake in shares of Progyny by 1,355.0% during the 4th quarter. Signaturefd LLC now owns 1,455 shares of the company’s stock valued at $25,000 after buying an additional 1,355 shares in the last quarter. GAMMA Investing LLC raised its holdings in Progyny by 341.4% during the 4th quarter. GAMMA Investing LLC now owns 1,611 shares of the company’s stock valued at $28,000 after acquiring an additional 1,246 shares during the period. Nisa Investment Advisors LLC lifted its position in shares of Progyny by 108.4% during the fourth quarter. Nisa Investment Advisors LLC now owns 2,934 shares of the company’s stock worth $51,000 after acquiring an additional 1,526 shares in the last quarter. Caitlin John LLC boosted its holdings in shares of Progyny by 2,974.8% in the fourth quarter. Caitlin John LLC now owns 3,290 shares of the company’s stock worth $57,000 after acquiring an additional 3,183 shares during the period. Finally, Natixis purchased a new position in shares of Progyny in the fourth quarter valued at $69,000. 94.93% of the stock is owned by hedge funds and other institutional investors.

Progyny Company Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.